Advertisement

La radiologia medica

, Volume 123, Issue 5, pp 323–330 | Cite as

Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change

  • Jiae Choi
  • Jeong-Sik Yu
  • Eun-Suk Cho
  • Joo Hee Kim
  • Jae-Joon Chung
ABDOMINAL RADIOLOGY
  • 111 Downloads

Abstract

Purpose

To investigate the very long-term (> 5 years) follow-up changes of hepatic cavernous hemangiomas and to evaluate possible determinant factors for the changes.

Materials and methods

Among 1115 consecutive patients suspected of having hepatic hemangiomas based on imaging features, 101 patients with comparable computed tomography or magnetic resonance imaging data during a 5-year follow-up interval in the Picture Archiving and Communication System were analyzed. Two radiologists independently determined the largest dimension of each lesion on axial images. In addition to background liver fibrosis or steatosis on imaging, histories of use of chemotherapeutic agents were checked from the patients’ records. The final size change of the hemangioma was categorized into three groups compared with the initial diameter (increased, > 120%; no change, 80–120%; decreased, < 80%).

Results

Among the 101 hemangiomas, 32 lesions (31.7%) were enlarged and 21 lesions (20.8%) were shrunken during intervals of 60–157 (median, 81) months. Younger patients showed a higher prevalence of lesion enlargement (mean age: enlarged, 47.3 years; no change, 52.8 years; shrunken, 57.1 years; p = 0.003). In 15 patients with cirrhosis, the lesions (shrunken, n = 7; enlarged, n = 1) showed a higher tendency of size decrease (p = 0.009), whereas other factors did not show statistical significance (p > 0.05). Only a minor proportion (1%, n = 1) of the lesions showed size fluctuation during follow-up.

Conclusion

During the long-term (5–13 years) follow-up, about 50% of the hepatic hemangiomas were enlarged or shrunken to > 20% of the initial diameter. Aside from the cirrhosis and aging factors, the size changes seemed sporadic.

Keywords

Hepatic hemangioma Interval change Computed tomography Magnetic resonance imaging Liver cirrhosis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

References

  1. 1.
    Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39:183–188CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bioulac-Sage P, Sempoux C, Balabaud C (2008) Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 28:302–314CrossRefPubMedGoogle Scholar
  3. 3.
    Hasan HY, Hinshaw JL, Borman EJ, Gegios A, Leverson G, Winslow ER (2014) Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg 149:1266–1271CrossRefPubMedGoogle Scholar
  4. 4.
    Jing L, Liang H, Caifeng L, Jianjun Y, Feng X, Mengchao W et al (2016) New recognition of the natural history and growth pattern of hepatic hemangioma in adults. Hepatol Res 46:727–733CrossRefPubMedGoogle Scholar
  5. 5.
    Conter RL, Longmire WP Jr (1988) Recurrent hepatic hemangiomas. Possible association with estrogen therapy. Ann Surg 207:115–119CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Glinkova V, Shevah O, Boaz M, Levine A, Shirin H (2004) Hepatic haemangiomas: possible association with female sex hormones. Gut 53:1352–1355CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities. Am J Roentgenol 173:1185–1192CrossRefGoogle Scholar
  8. 8.
    Yu JS, Kim KW, Park MS, Yoon SW (2000) Hepatic cavernous hemangioma in cirrhotic liver: imaging findings. Koran J Radiol 1:185–190CrossRefGoogle Scholar
  9. 9.
    Brancatelli G, Federle MP, Blachar A, Grazioli L (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219:69–74CrossRefPubMedGoogle Scholar
  10. 10.
    Yu JS, Kim KW, Kim YH et al (1998) Comparison of multishot turbo spin echo and HASTE sequences for T2-weighted MRI of liver lesions. J Magn Reson Imaging 8:1079–1084CrossRefPubMedGoogle Scholar
  11. 11.
    Yu JS, Kim KW, Park MS, Yoon SW (2002) Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma. J Comput Assist Tomogr 26:411–417CrossRefPubMedGoogle Scholar
  12. 12.
    Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM (2009) “Pseudo washout” sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. Am J Roentgenol 193:W490–W496CrossRefGoogle Scholar
  13. 13.
    Park YS, Park SH, Lee SS, Kim DY, Shin YM, Lee W et al (2011) Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 258:760–766CrossRefPubMedGoogle Scholar
  14. 14.
    Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T (2015) Hepatic hemangioma—review. J Med Life 8:4–11PubMedPubMedCentralGoogle Scholar
  15. 15.
    Schnaper HW, McGowan KA, Kim-Schulze S et al (1996) Oestrogen and endothelial cell angiogenic activity. Clin Exp Pharmacol Physiol 23:247–250CrossRefPubMedGoogle Scholar
  16. 16.
    Giannitrapani L, Soresi M, La Spada E et al (2006) Sex hormones and risk of liver tumor. Ann N Y Acad Sci 1089:228–236CrossRefPubMedGoogle Scholar
  17. 17.
    Kim GE, Thung SN, Tsui WM, Ferrell LD (2006) Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int 26:334–338CrossRefPubMedGoogle Scholar
  18. 18.
    Schoen FJ, Cotran RS (1999) Blood vessels. In: Cotran RS, Kumar V, Collins T (eds) Pathologic bases of disease, 6th edn. WB Saunders, Philadelphia, pp 493–541Google Scholar
  19. 19.
    Baker ER, Manders E, Whitney CW (1985) Growth of cavernous hemangioma with puberty. Clin Pediatr 24:596–598CrossRefGoogle Scholar
  20. 20.
    Li Y, Jia Y, Li S, Wang W, Wang Z, Wang Y et al (2015) Transarterial chemoembolization of giant liver haemangioma: a multi-center study with 836 cases. Cell Biochem Biophys 73:469–472CrossRefPubMedGoogle Scholar
  21. 21.
    Takahashi T, Kuwao S, Katagiri H et al (1998) Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis. Dig Dis Sci 43:1553–1561CrossRefPubMedGoogle Scholar
  22. 22.
    Jaggers DC, Collins WP, Milligan SR (1996) Potent inhibitory effects of steroids in an in vitro model of angiogenesis. J Endocrinol 150:457–464CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Medical Radiology 2018

Authors and Affiliations

  1. 1.Department of Radiology, Gangnam Severance HospitalYonsei University College of MedicineSeoulSouth Korea

Personalised recommendations